Who is being investigated following the MedWatch findings?
Giorgos Patoulis, President of the ISA, and pediatrician Maria Karystianou, President of 'Elpida gia ti Dimokratia', are currently subject to regulatory reviews following alerts from the MedWatch platform. Health Minister Adonis Georgiadis has emphasized that both individuals maintain the presumption of innocence as investigations proceed. The Minister clarified that the Ministry of Health does not conduct these audits directly; instead, the responsibility lies with the Medical Associations and the National Transparency Authority.
The procedural paths for these investigations differ based on the nature of the alerts. In the case of Mr. Patoulis, the Panhellenic Medical Association (PIS) collected the relevant complaints and forwarded the file to the National Transparency Authority. For Ms. Karystianou, the MedWatch algorithm flagged her practice with a 'yellow' status, prompting the Thessaloniki Medical Association to initiate a formal check. Georgiadis noted that while some 'red' findings are reviewed and dismissed, others require rigorous follow-up to ensure public trust is maintained. The Minister highlighted that the disclosure of these names was necessary due to their status as public figures, aiming to restore a climate of trust.
The Role of Public Figures in Regulatory Transparency
The decision to disclose the names of high-profile medical professionals like Patoulis and Karystianou has been a point of contention. However, the Health Minister argued that because they are public figures, transparency is essential to restore and maintain public confidence in the healthcare system. He stressed that the vast majority of practitioners—well under 1%—are not violators, and the goal is to isolate the small fraction of non-compliant actors without undermining the reputation of the medical profession as a whole.
By naming these individuals, the Ministry seeks to demonstrate that no one is above the scrutiny provided by new digital tools. Georgiadis emphasized that the public should continue to have confidence in their doctors, as the current findings represent a very small minority of the medical community. The focus remains on ensuring that the oversight process is seen as impartial and thorough, moving from initial AI flags to formal investigations by the appropriate professional bodies.
How does the MedWatch platform detect medical violations?
The MedWatch platform utilizes advanced artificial intelligence and large language models to scan digital footprints for non-compliant medical content. Rather than manually reviewing every website, the system pulls data from public sources to identify potential infractions. During its first ten days of operation, the platform's scope expanded significantly, increasing the volume of examined content from 13,101 to 37,216 entries. This includes 17,360 paid advertisements, 17,570 websites, and 2,287 public posts.
The AI functions as a screening tool rather than a final judge. It identifies 'candidate findings'—instances where digital content appears to violate existing laws—and assigns them a color-coded status. These findings are then passed to the relevant Medical Associations for human evaluation. Crucially, the system does not collect patient data, ensuring that privacy remains intact while the digital oversight of medical claims is tightened. Currently, the system covers approximately 70% of Greece's healthcare structures, specifically targeting the major hubs of Athens, Piraeus, and Thessaloniki. With the inclusion of Piraeus and Thessaloniki, the platform now monitors 12,137 structures, up from the initial 8,628.
What are the most common violations identified by the system?
The most striking result of the MedWatch implementation is a 91% drop in illegal medical advertising. This decline suggests that the mere presence of automated monitoring has acted as a deterrent. The system has categorized several major types of violations that pose risks to public health and consumer protection.
- Cosmetic Misuse of Toxins: The platform identified 119 instances in dental practices involving the use of hyaluronic acid, mesotherapy, and Botox for non-therapeutic purposes. Under 2026 regulations, dentists are permitted to use botulinum toxin strictly for therapeutic reasons, not for aesthetic enhancements.
- Unregulated Biological Treatments: There were 231 findings related to stem cell treatments in clinics and aesthetic centers, many of which lack the necessary approval from the National Organization for Medicines (EOF). This includes 24 findings in aesthetic centers and 29 in clinics.
- Prohibited Weight Loss Claims: MedWatch flagged 911 pieces of content promoting injectable weight loss treatments, such as Botox and Dysport, which are prohibited from being advertised in this manner.
- Non-Medical Advertising: The system detected 468 'red' findings where individuals without medical qualifications were advertising medical procedures.
According to Yannis Doxaras, CEO of Warply, the number of findings has tripled following the expansion into Piraeus and Thessaloniki. Despite the high number of flags, the data shows a downward trend in 'red' indicators, suggesting that many practitioners are proactively adjusting their digital presence to comply with the law. Doxaras noted that while there were 141 medical advertising campaigns running on September 10, that number had dropped to just 13 by the time of the recent report.
What is the future scope of MedWatch oversight?
The MedWatch project is set to expand its reach beyond general medical practitioners to cover a much broader spectrum of healthcare professionals. The next phase of implementation will include dentists, physiotherapists, dietitians, and psychologists. This expansion aims to create a comprehensive digital safety net for all health-related services provided in the private sector.
As the platform's coverage grows, the ability to monitor the digital landscape in real-time will increase. The objective is to move from a reactive model to a continuous monitoring system where compliance is the standard. By integrating more medical associations into the workflow, the platform ensures that the final decision-making power remains in the hands of professional medical bodies, while the AI provides the necessary data to make those decisions more efficient and evidence-based. Doxaras emphasized that as coverage expands, monitoring will become increasingly seamless.
FAQ: MedWatch and Medical Regulation
Is MedWatch making legal decisions on medical practices?
No, MedWatch does not issue final rulings or penalties. The platform uses AI to identify potential violations and flags them as 'candidate findings.' The final evaluation and any subsequent disciplinary actions are carried out exclusively by the relevant Medical Associations and regulatory authorities.
Does the MedWatch system access private patient information?
The system does not collect or process patient data. MedWatch exclusively gathers information from public digital sources, such as websites, social media posts, and advertisements, to ensure that the monitoring process respects individual privacy and medical confidentiality.
Why has medical advertising decreased so significantly?
The 91% decrease in medical advertising is attributed to the deterrent effect of the platform. The knowledge that AI is actively monitoring digital content for compliance has encouraged many practitioners to remove prohibited advertisements and align their marketing with current legal standards.
What happens if a doctor receives a 'yellow' flag?
A 'yellow' flag indicates a potential irregularity that requires further scrutiny but may not be a direct violation. In such cases, the matter is referred to the local Medical Association, which conducts a manual investigation to determine if further action is necessary.
Which medical professions will be monitored next?
The platform is expanding its scope beyond the current coverage to include dentists, physiotherapists, dietitians, and psychologists. This expansion is intended to ensure that all healthcare providers operating in the digital space are subject to consistent regulatory oversight.
Key takeaways
- The MedWatch platform has achieved a 91% reduction in illegal medical advertising in Greece.
- AI monitoring now covers approximately 70% of Greece's private healthcare structures.
- The system identifies violations in dentistry, stem cell use, and prohibited weight loss claims.
- Final disciplinary decisions remain the sole responsibility of Medical Associations.
Conclusion
The deployment of the MedWatch platform marks a turning point in the regulation of the Greek healthcare sector. By leveraging artificial intelligence to monitor the digital landscape, authorities have successfully curtailed a significant volume of non-compliant medical advertising. While the initial phase has highlighted numerous irregularities—ranging from the cosmetic misuse of toxins to unauthorized stem cell treatments—the overall trend shows increasing compliance. As the system expands to include dietitians, psychologists, and other specialists, it promises to create a more transparent and safer environment for patients navigating the complexities of modern digital healthcare.
